MLICM
NEXI

Metropolitan Life Insurance Company (MetLife)’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio NEXI Stock Details NEXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-233
Closed -$88.2K – 2842
2021
Q3 		$88.2K Buy
+233
New +$78.1K ﹤0.01% 2597

Other funds holding NEXI

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AO
Allen Operations New York $722M AUM 20.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s NEXI Position: Q4 2021 in Review

Metropolitan Life Insurance Company (MetLife) sold out of NexImmune, Inc. Common Stock (NEXI) in Q4 2021, closing a stake of 233 shares — an estimated $88.2K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in NEXI in Q3 2021 and held it in 1 quarter. The position peaked at $88.2K in Q3 2021. 46 funds tracked by Wall St. Rank hold NEXI as of Q4 2021.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining NexImmune, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 233 NexImmune, Inc. Common Stock shares in Q4 2021, an estimated $88.2K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in NexImmune, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • Metropolitan Life Insurance Company (MetLife)'s NexImmune, Inc. Common Stock position peaked at $88.2K in Q3 2021.
  • 46 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q4 2021.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2021, filed 15 Feb 2022.